Next Article in Journal
Design of Experiment (DOE) Utilization to Develop a Simple and Robust Reversed-Phase HPLC Technique for Related Substances’ Estimation of Omeprazole Formulations
Previous Article in Journal
Determination of Cephalexin Monohydrate in Pharmaceutical Dosage Form by Stability-Indicating RP-UFLC and UV Spectroscopic Methods
 
 
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Scientia Pharmaceutica, Autorenhinweise 2012

by
Scientia Pharmaceutica Editorial Office
Submission received: 23 December 2011 / Accepted: 23 December 2011 / Published: 23 December 2011

Abstract

No abstract available

Share and Cite

MDPI and ACS Style

Scientia Pharmaceutica Editorial Office. Scientia Pharmaceutica, Autorenhinweise 2012. Sci. Pharm. 2012, 80, 251-264. https://0-doi-org.brum.beds.ac.uk/10.3797/scipharm.aut-12-01

AMA Style

Scientia Pharmaceutica Editorial Office. Scientia Pharmaceutica, Autorenhinweise 2012. Scientia Pharmaceutica. 2012; 80(1):251-264. https://0-doi-org.brum.beds.ac.uk/10.3797/scipharm.aut-12-01

Chicago/Turabian Style

Scientia Pharmaceutica Editorial Office. 2012. "Scientia Pharmaceutica, Autorenhinweise 2012" Scientia Pharmaceutica 80, no. 1: 251-264. https://0-doi-org.brum.beds.ac.uk/10.3797/scipharm.aut-12-01

Article Metrics

Back to TopTop